Does the addition of erlotinib to gemcitabine improve outcome in patients with advanced pancreatic cancer?

被引：0
|
作者：
Helmut Oettle
Andreas Hilbig
机构：
[1] Berlin,H Oettle is an Associate Professor and A Hilbig is a Clinical Research Fellow in the Department of Medical Oncology and Hematology at the Charité School of Medicine
[2] Germany.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：686 / 687
页数：1
相关论文
共 50 条
  • [21] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [22] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [23] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [24] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [25] Adjuvant Gemcitabine and Erlotinib for Resected Pancreatic Cancer
    Bao, P.
    Ramanathan, R. K.
    Moser, A. J.
    Bahary, N.
    Lembersky, B. C.
    Bartlett, D. L.
    Hughes, S. J.
    Lee, K. K.
    Zeh, H. J.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S66 - S66
  • [26] Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
    Epelbaum, Ron
    Schaffer, Moshe
    Vizel, Bella
    Badmaev, Vladimir
    Bar-Sela, Gil
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (08): : 1137 - 1141
  • [27] Gemcitabine in elderly patients with advanced pancreatic cancer
    Olivia Hentic
    Vinciane Rebours
    Philippe Lévy
    Philippe Ruszniewski
    Pascal Hammel
    Magaly Zappa
    Chantal Dreyer
    Eric Raymond
    World Journal of Gastroenterology, 2011, 17 (30) : 3497 - 3502
  • [28] Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer
    Ko, Andrew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (30) : 4711 - +
  • [29] Gemcitabine in elderly patients with advanced pancreatic cancer
    Hentic, Olivia
    Dreyer, Chantal
    Rebours, Vinciane
    Zappa, Magaly
    Levy, Philippe
    Raymond, Eric
    Ruszniewski, Philippe
    Hammel, Pascal
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (30) : 3497 - 3502
  • [30] Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?
    Miksad, Rebecca A.
    Schnipper, Lowell
    Goldstein, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4506 - 4507
12345